Non-clinical safety of monoclonal antibodies for human use

被引：0
|
作者：
Suzuki-Nishimura, Tamiko [1 ]
机构：
[1] Pharmaceut & Med Devices Agcy, Tokyo 1000013, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2008年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：148P / 148P
页数：1
相关论文
共 50 条
  • [31] USE OF MONOCLONAL-ANTIBODIES IN HUMAN TRANSPLANTATION
    DANTAL, J
    SOULILLOU, JP
    CURRENT OPINION IN IMMUNOLOGY, 1991, 3 (05) : 740 - 747
  • [32] THERAPEUTIC USE OF HUMAN MONOCLONAL-ANTIBODIES
    CRAWFORD, DH
    HUEHNS, ER
    EPSTEIN, MA
    LANCET, 1983, 1 (8332): : 1040 - 1040
  • [33] The use of monoclonal antibodies in human prion disease
    Bodemer, W
    NATURWISSENSCHAFTEN, 1999, 86 (05) : 212 - 220
  • [34] Non-Clinical Safety Evaluation of Intranasal Iota-Carrageenan
    Hebar, Alexandra
    Koller, Christiane
    Seifert, Jan-Marcus
    Chabicovsky, Monika
    Bodenteich, Angelika
    Bernkop-Schnuerch, Andreas
    Grassauer, Andreas
    Prieschl-Grassauer, Eva
    PLOS ONE, 2015, 10 (04):
  • [35] Designing non-clinical safety evaluation programmes: The view of the clinician
    Lipani, J
    SAFETY EVALUATION OF BIOTECHNOLOGICALLY-DERIVED PHARMACEUTICALS: FACILITATING A SCIENTIFIC APPROACH, 1998, : 1 - 6
  • [36] Non-clinical Safety Assessment of Angiotensin 1-7
    Thun, S.
    Petersen, K. U.
    Christoph, T.
    Schmitz, U.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 : S79 - S79
  • [37] Safety Behaviours, Rumination and Trait Paranoia in a Non-Clinical Sample
    Simpson, Jennifer
    MacGregor, Bryony
    Cavanagh, Kate
    Dudley, Robert E. J.
    JOURNAL OF EXPERIMENTAL PSYCHOPATHOLOGY, 2012, 3 (04): : 612 - 623
  • [38] Points to consider on the non-clinical safety evaluation of anticancer drugs
    Nakae, Dai
    Onodera, Horoshi
    Fueki, Osamu
    Urano, Tsutomu
    Komiyama, Noriyuki
    Sagami, Fumio
    Kai, Shuichi
    Nishimura, Chihiro
    Inoue, Tohru
    JOURNAL OF TOXICOLOGICAL SCIENCES, 2008, 33 (02): : 123 - 126
  • [39] Considerations for non-clinical safety studies of therapeutic peptide vaccines
    Matsumoto, Mineo
    Komatsu, Shinichi
    Tsuchimoto, Mayumi
    Matsui, Hajime
    Watanabe, Kazuto
    Nakamura, Kazuichi
    Amakasu, Kohei
    Ito, Kanako
    Fueki, Osamu
    Sawada, Jun-ichi
    Maki, Kazushige
    Onodera, Hiroshi
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2014, 70 (01) : 254 - 260
  • [40] Designing non-clinical safety evaluation programmes: The view of the toxicologist
    Dempster, M
    SAFETY EVALUATION OF BIOTECHNOLOGICALLY-DERIVED PHARMACEUTICALS: FACILITATING A SCIENTIFIC APPROACH, 1998, : 7 - 15
12345